The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) Book/Monograph |
| Language: | English |
| Published: |
London Berlin, Heidelberg
BioMed Central ; Springer
2018
Heidelberg Universitätsbibliothek Heidelberg 2018 |
| DOI: | https://doi.org/10.1186/s12885-018-5126-7 |
| Online Access: | Resolving-System, kostenfrei, Volltext: http://dx.doi.org/https://doi.org/10.1186/s12885-018-5126-7 Resolving-System, kostenfrei, Volltext: http://nbn-resolving.de/urn:nbn:de:bsz:16-heidok-257244 
|
| Author Notes: | Marilena Petrera, Laura Paleari, Matteo Clavarezza, Matteo Puntoni, Silvia Caviglia, Irene Maria Briata, Massimo Oppezzi, Eva Mihajlovic Mislej, Borut Stabuc, Michael Gnant, Thomas Bachleitner-Hofmann, Wilfried Roth, Dominique Scherer, Walter-E. Haefeli, Cornelia M. Ulrich and Andrea DeCensi |
| Item Description: | Aus: BMC Cancer, 18 (2018), Nr. 1210. pp. 1-9. ISSN 1471-2407 |
|---|---|
| Physical Description: | Online Resource |
| DOI: | https://doi.org/10.1186/s12885-018-5126-7 |